RE:Mice trialsPhase 1 trials basically show humans aren't poisoned by the substance and if they are they can find an ideal dosage , if they isn't any side effects they can proceed to phase 2 witth real MS patients if they pass phase 1
Future could be bright if good data from phase 1 and 2
aside from current stock price it can go to zero or hero nobody knows
FSD needs more capital they have warrants in place ranging from $1.80, $4 and $10